Full Text View
Tabular View
No Study Results Posted
Related Studies
One Year Study to Evaluate Three Different Adjuvanted Doses of the Recombinant Plague Vaccine (rF1 and rV Antigens)
This study has been completed.
Study NCT00246467   Information provided by PharmAthene UK Limited
First Received: October 27, 2005   Last Updated: September 12, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Plague
More general conditions related to this trial
Bacterial Infections
Enterobacteriaceae Infections
Gram-Negative Bacterial Infections
Yersinia Infections
Interventions listed in this trial
Alhydrogel
rF1 and rV protein antigens
Additional drug interventions recognized in this trial
Aluminum Hydroxide
More general drug interventions related to this trial
Adjuvants, Immunologic
Antacids
Immunologic Factors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
PharmAthene UK Limited
National Institute of Allergy and Infectious Diseases (NIAID)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services